MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jmedchem.4c02555

Медицинская библиотека · Journal of medicinal chemistry · 2025

Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease.

Doskey Luke C, Scholtz Cole R, Vail Nora R, Khanal Shalil, Lee Amani L, Kandanur Sai Giridhar Sarma, Hoell Zachariah J, Huehls Amelia M, Issa Mohamed R, Kostallari Enis, Cao Sheng, Reid Joel M, Shah Vijay H, Malhi Harmeet, Pomerantz William C K

СтатьяПеревод пока не подготовлен

Аннотация

BET bromodomain inhibitors demonstrate significant promise as anti-inflammatory agents. However, clinical data demonstrated that nonselective BET bromodomain inhibitors led to significant dose-limiting toxicity in clinical settings. Here, we use three orally bioavailable inhibitors, 1-3, that are either BRD4-D1 selective or pan-D1-biased + BRD4-D2, for assessing their cellular and in vivo efficacy and safety profile compared to known BET inhibitors in two inflammatory disease models. Our results show that pan-D1-biased + BRD4-D2 inhibitor, 3, is as efficacious as pan-BET inhibitor, I-BET151, in reducing inflammation in both models, whereas pan-D2 inhibitors are less effective. BRD4-D1 selective inhibitors are also efficacious; however, inhibitors with improved cellular engagement will be necessary to better assess their effects. Finally, BRD4-D1 selective inhibitors are better tolerated in a preclinical thrombocytopenia model than 3, while gastrointestinal toxicity may be a BRD4-driven effect. These results highlight the importance of assessing specific BET bromodomain functions due to their diverse roles in disease models.

Для цитирования: Doskey Luke C, Scholtz Cole R, Vail Nora R, Khanal Shalil, Lee Amani L, Kandanur Sai Giridhar Sarma, Hoell Zachariah J, Huehls Amelia M, Issa Mohamed R, Kostallari Enis, Cao Sheng, Reid Joel M, Shah Vijay H, Malhi Harmeet, Pomerantz William C K. Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease.. Journal of medicinal chemistry. 2025. DOI: 10.1021/acs.jmedchem.4c02555.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.